Thrombosis, prevalence and new evidence on current perceptions of risk

Cancer Treatment Reviews

Volumn 29, Issue SUPPL. 2, 2003, Pages 3-5

  Pinedo, Herbert M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cancer patients; Clinician survey; Thrombosis risk; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; BRAIN CANCER; CANCER PATIENT; CLINICAL PRACTICE; COLORECTAL CANCER; GENERAL PRACTITIONER; HEALTH SURVEY; HEMATOLOGY; HIGH RISK PATIENT; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SPECIALIST; OVARY CANCER; PANCREAS CANCER; PATIENT CARE; PHYSICIAN ATTITUDE; PREVALENCE; PROSTATE CANCER; RISK ASSESSMENT; STOMACH CANCER; SURGEON; THROMBOEMBOLISM; TUMOR LOCALIZATION; UTERINE CERVIX CANCER; VEIN THROMBOSIS;

EID: 0037531591     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(03)80001-4     Document Type: Article

References (7)

1. Prandoni P, Lensing AW, Buller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten Cate JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-1133.
2. Kakkar A, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson R. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-1005.
3. Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboembolism: an overview. Haematologica 1999; 84: 437-445.
4. Levitan N, Dowlati A, Remick S, Tahsildar H, Sivinski L, Beyth R, Rimm A. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 1999; 78: 285-291.
5. Sproul E. Carcinoma and venous thrombosis: The frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938; 34: 566-585.
6. Lindblad B, Sternby N, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991; 302: 709-711.
7. Shen V, Pollak E. Fatal pulmonary embolism in cancer patients: Is heparin prophylaxis justified? South Med J 1980; 73: 841-843.